seed
Stage
1
Investors
About
RSPR Pharma develops small molecule drugs targeting RNA-binding proteins to treat rare and genetically defined cancers and neurological diseases.
Explore RSPR Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.